Used as a building block in the synthesis of biologically active compounds, particularly in pharmaceutical research. Its structure supports the development of protease inhibitors and other enzyme-targeted drugs. The presence of trifluoromethyl and tosyl groups enhances metabolic stability and binding selectivity, making it valuable in designing drug candidates with improved pharmacokinetic properties. Commonly employed in asymmetric synthesis due to its functional group compatibility.